# FDA Inspection 1216777 - Oishi Koseido Co., Ltd. - September 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/oishi-koseido-co-ltd/9e21866d-cca2-4a4d-aa64-3954fb5fe0ea
Source feed: FDA_Inspections

> FDA Inspection 1216777 for Oishi Koseido Co., Ltd. on September 01, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216777
- Company Name: Oishi Koseido Co., Ltd.
- Inspection Date: 2023-09-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1037551 - 2017-12-08](https://www.keypedia.com/records/fda_inspections/oishi-koseido-co-ltd/5493c4d5-6dda-4a7d-bbbb-61e50fd8b7cc)
- [FDA Inspection 956220 - 2016-01-29](https://www.keypedia.com/records/fda_inspections/oishi-koseido-co-ltd/02961efe-e59f-46e7-8d55-25d786a0dcdd)

Company: https://www.keypedia.com/companies/oishi-koseido-co-ltd/07ae7f38-2728-4248-8ef1-ff0abd9a79e7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c